Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity

Michael Haupts,Carlos Vila,Anna Jonas,Kerstin Witte,Lourdes Álvarez-Ossorio

Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity

2016

Michael Haupts
Carlos Vila
Anna Jonas
Kerstin Witte
Lourdes Álvarez-Ossorio

Background: Sativex® (THC:CBD oromucosal spray) is indicated as add-on treatment for patients with moderate to severe multiple sclerosis (MS) spasticity. We aimed

Keywords:

Clonidine
Cannabidiol
Anesthesia
Medicine
Baclofen
Multiple sclerosis
Tizanidine
Spasticity
Dronabinol
Tolerability

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations